Danimer Scientific (NYSE:DNMR) Stock Rating Lowered by Jefferies Financial Group

Danimer Scientific (NYSE:DNMRGet Free Report) was downgraded by equities research analysts at Jefferies Financial Group from a “buy” rating to a “hold” rating in a report issued on Wednesday, MarketBeat.com reports. They currently have a $0.80 price objective on the stock, down from their previous price objective of $1.30. Jefferies Financial Group’s target price points to a potential upside of 13.43% from the stock’s current price.

DNMR has been the subject of several other reports. TD Cowen decreased their price objective on shares of Danimer Scientific from $2.25 to $1.50 and set a “buy” rating for the company in a research note on Thursday, April 4th. Piper Sandler reaffirmed a “neutral” rating and issued a $0.94 price target (down from $2.63) on shares of Danimer Scientific in a report on Tuesday, April 9th.

View Our Latest Stock Analysis on Danimer Scientific

Danimer Scientific Price Performance

NYSE DNMR opened at $0.71 on Wednesday. The company has a market cap of $82.12 million, a price-to-earnings ratio of -0.50 and a beta of 1.62. The company has a debt-to-equity ratio of 1.50, a current ratio of 6.54 and a quick ratio of 4.91. The stock’s fifty day moving average price is $0.72 and its 200 day moving average price is $0.78. Danimer Scientific has a 1 year low of $0.60 and a 1 year high of $3.49.

Danimer Scientific (NYSE:DNMRGet Free Report) last announced its quarterly earnings data on Thursday, March 28th. The company reported ($0.29) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.29). Danimer Scientific had a negative return on equity of 49.97% and a negative net margin of 324.79%. The business had revenue of $10.95 million for the quarter, compared to analyst estimates of $10.90 million. As a group, equities research analysts forecast that Danimer Scientific will post -0.9 earnings per share for the current year.

Institutional Trading of Danimer Scientific

A number of hedge funds have recently added to or reduced their stakes in the company. Principal Financial Group Inc. acquired a new position in shares of Danimer Scientific during the 3rd quarter worth approximately $27,000. SG Americas Securities LLC purchased a new stake in Danimer Scientific in the 4th quarter worth $41,000. Levin Capital Strategies L.P. raised its position in Danimer Scientific by 423.3% during the fourth quarter. Levin Capital Strategies L.P. now owns 78,500 shares of the company’s stock worth $80,000 after acquiring an additional 63,500 shares during the period. Raymond James & Associates lifted its holdings in Danimer Scientific by 10.1% during the third quarter. Raymond James & Associates now owns 76,875 shares of the company’s stock valued at $159,000 after purchasing an additional 7,040 shares in the last quarter. Finally, Virtu Financial LLC grew its position in shares of Danimer Scientific by 628.5% in the fourth quarter. Virtu Financial LLC now owns 182,078 shares of the company’s stock valued at $186,000 after purchasing an additional 157,085 shares during the period. 33.84% of the stock is owned by hedge funds and other institutional investors.

Danimer Scientific Company Profile

(Get Free Report)

Danimer Scientific, Inc, a performance polymer company, provides bioplastic replacements for traditional petroleum-based plastics in the United States, Germany, Poland, Belgium, Austria, and internationally. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative under the Nodax brand name for applications in films, straws, cutlery, food containers, and others; polylactic acid-based resins for coating disposable paper cups; and other biopolymers.

Recommended Stories

Receive News & Ratings for Danimer Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danimer Scientific and related companies with MarketBeat.com's FREE daily email newsletter.